Products - Systemic lupus erythematosus | Topic | NICE

Showing 2 products

Date | Title

New and updated: New in the last 6 monthsRemove ‘New and updated: New in the last 6 months’ filter

Obinutuzumab with immunosuppressive therapies for treating lupus nephritis [ID6420]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
11 March 2026
Obinutuzumab for treating serologically active extra-renal lupus [ID6670]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC